{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:47:25Z","timestamp":1775472445443,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273530"],"award-info":[{"award-number":["82273530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02471-0","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T18:14:53Z","timestamp":1772302493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Secondary Exposure to IMQ or Irritants Enhances Psoriasiform Recurrence Through Inflammatory Memory"],"prefix":"10.1007","volume":"49","author":[{"given":"Wenqiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"2","key":"2471_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek, I.M., B. Loring, and S.M. John. 2017. A systematic review of worldwide epidemiology of psoriasis. Journal of the European Academy of Dermatology and Venereology 31 (2): 205\u2013212. https:\/\/doi.org\/10.1111\/jdv.13854.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"10281","key":"2471_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C.E.M., A.W. Armstrong, J.E. Gudjonsson, and J.N.W.N. Barker. 2021. Psoriasis. Lancet 397 (10281): 1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"issue":"2","key":"2471_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/JD9.0000000000000300","volume":"7","author":"AJ Chen","year":"2024","unstructured":"Chen, A.J., D.X. Cai, and X. Chen. 2024. Expert consensus on the treat-to-target strategy for psoriasis with biological agents in China. International Journal of Dermatology and Venereology 7 (2): 61\u201369. https:\/\/doi.org\/10.1097\/JD9.0000000000000300.","journal-title":"International Journal of Dermatology and Venereology"},{"issue":"3","key":"2471_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2022.100116","volume":"2","author":"D Tian","year":"2022","unstructured":"Tian, D., and Y. Lai. 2022. The relapse of psoriasis: Mechanisms and mysteries. JID Innovations 2 (3): 100116. https:\/\/doi.org\/10.1016\/j.xjidi.2022.100116.","journal-title":"JID Innovations"},{"key":"2471_CR5","doi-asserted-by":"publisher","first-page":"109897","DOI":"10.1016\/j.intimp.2023.109897","volume":"117","author":"S Parab","year":"2023","unstructured":"Parab, S., and G. Doshi. 2023. The experimental animal models in psoriasis research: A comprehensive review. International Immunopharmacology 117:109897. https:\/\/doi.org\/10.1016\/j.intimp.2023.109897","journal-title":"International Immunopharmacology"},{"issue":"10091","key":"2471_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(17)31279-5","volume":"390","author":"K Reich","year":"2017","unstructured":"Reich, K., K.A. Papp, A. Blauvelt, et al. 2017. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): Results from two randomised controlled, phase 3 trials. Lancet 390 (10091): 276\u2013288. https:\/\/doi.org\/10.1016\/S0140-6736(17)31279-5.","journal-title":"Lancet"},{"issue":"2","key":"2471_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/ijms21020625","volume":"21","author":"A Owczarczyk Saczonek","year":"2020","unstructured":"Owczarczyk Saczonek, A., M. Krajewska-W\u0142odarczyk, and M. Kasprowicz-Furma\u0144czyk et al. 2020. Immunological memory of psoriatic lesions. International Journal of Molecular Sciences 21(2):625. https:\/\/doi.org\/10.3390\/ijms21020625","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"2471_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00281-019-00766-z","volume":"41","author":"T Benezeder","year":"2019","unstructured":"Benezeder, T., and P. Wolf. 2019. Resolution of plaque-type psoriasis: What is left behind (and reinitiates the disease). Seminars in Immunopathology 41(6):633\u2013644. https:\/\/doi.org\/10.1007\/s00281-019-00766-z","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"2471_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","volume":"147","author":"MP Sch\u00f6n","year":"2021","unstructured":"Sch\u00f6n, M.P., V. Manzke, and L. Erpenbeck. 2021. Animal models of psoriasis-highlights and drawbacks. Journal of Allergy and Clinical Immunology 147 (2): 439\u2013455. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.034.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"12","key":"2471_CR10","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B., and F.O. Nestle. 2013. TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis. European Journal of Immunology 43 (12): 3138\u20133146. https:\/\/doi.org\/10.1002\/eji.201343801.","journal-title":"European Journal of Immunology"},{"issue":"1","key":"2471_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ygeno.2012.05.004","volume":"100","author":"AB Coda","year":"2012","unstructured":"Coda, A.B., M. Icen, J.R. Smith, et al. 2012. Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic \u201chot spots\u201d for differentially expressed genes. Genomics 100 (1): 18\u201326. https:\/\/doi.org\/10.1016\/j.ygeno.2012.05.004.","journal-title":"Genomics"},{"key":"2471_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2566","volume":"4","author":"A Walter","year":"2013","unstructured":"Walter, A., M. Sch\u00e4fer, V. Cecconi, et al. 2013. Aldara activates TLR7-independent immune defence. Nature Communications 4: 1560. https:\/\/doi.org\/10.1038\/ncomms2566.","journal-title":"Nature Communications"},{"issue":"7677","key":"2471_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik, S., S.B. Larsen, N.C. Gomez, et al. 2017. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550 (7677): 475\u2013480. https:\/\/doi.org\/10.1038\/nature24271.","journal-title":"Nature"},{"key":"2471_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112704","volume":"139","author":"L Yan","year":"2024","unstructured":"Yan, L., W. Wang, Y. Qiu, et al. 2024. Role of glucose metabolism reprogramming in keratinocytes in the link between psoriasis and metabolic syndrome. International Immunopharmacology 139: 112704. https:\/\/doi.org\/10.1016\/j.intimp.2024.112704.","journal-title":"International Immunopharmacology"},{"key":"2471_CR15","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.2147\/CCID.S422355","volume":"16","author":"L Yan","year":"2023","unstructured":"Yan, L., C. Yu, Z. Zhao, et al. 2023. Higher IL-9 level is associated with psoriasis vulgaris complicated by metabolic syndrome. Clinical, Cosmetic & Investigational Dermatology 16: 2297\u20132307. https:\/\/doi.org\/10.2147\/CCID.S422355.","journal-title":"Clinical, Cosmetic & Investigational Dermatology"},{"issue":"3","key":"2471_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar, R.S., J.E. Gudjonsson, and N.L. Ward. 2022. Mouse models of psoriasis: A comprehensive review. Journal of Investigative Dermatology 142 (3): 884\u2013897. https:\/\/doi.org\/10.1016\/j.jid.2021.06.019.","journal-title":"Journal of Investigative Dermatology"},{"issue":"12","key":"2471_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122514","volume":"18","author":"K Boche\u0144ska","year":"2017","unstructured":"Boche\u0144ska, K., E. Smoli\u0144ska, M. Moskot, et al. 2017. Models in the research process of psoriasis. International Journal of Molecular Sciences 18 (12): 2514. https:\/\/doi.org\/10.3390\/ijms18122514.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"2471_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/sj.jid.5700807","volume":"127","author":"JE Gudjonsson","year":"2007","unstructured":"Gudjonsson, J.E., A. Johnston, M. Dyson, et al. 2007. Mouse models of psoriasis. Journal of Investigative Dermatology 127 (6): 1292\u20131308. https:\/\/doi.org\/10.1038\/sj.jid.5700807.","journal-title":"Journal of Investigative Dermatology"},{"issue":"9","key":"2471_CR19","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van der Fits","year":"2009","unstructured":"Van der Fits, L., S. Mourits, J.S.A. Voerman, et al. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. Journal of Immunology (Baltimore, Md.\u202f: 1950) 182 (9): 5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"5","key":"2471_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos, S., A.N. Mohebiany, A. Waisman, et al. 2019. Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. Journal of Investigative Dermatology 139 (5): 1110\u20131117. https:\/\/doi.org\/10.1016\/j.jid.2019.01.006.","journal-title":"Journal of Investigative Dermatology"},{"issue":"23","key":"2471_CR21","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.7150\/thno.45211","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Y. Yan, H. Liu, et al. 2020. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8\u2009+\u2009T-cell memory in wild-type and humanized mice. Theranostics 10 (23): 10466\u201310482. https:\/\/doi.org\/10.7150\/thno.45211.","journal-title":"Theranostics"},{"issue":"4","key":"2471_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","volume":"141","author":"N Garzorz-Stark","year":"2018","unstructured":"Garzorz-Stark, N., F. Lauffer, and L. Krause et al. 2018. Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects. The Journal of Allergy and Clinical Immunology 141(4):1320\u20131333e11. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.045","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"2471_CR23","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12272-014-0496-0","volume":"38","author":"NM Kulkarni","year":"2015","unstructured":"Kulkarni, N.M., M.M. Muley, M.S. Jaji, et al. 2015. Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-\u03baB activation. Archives of Pharmacal Research 38 (6): 1238\u20131247. https:\/\/doi.org\/10.1007\/s12272-014-0496-0.","journal-title":"Archives of Pharmacal Research"},{"issue":"23","key":"2471_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312522","volume":"25","author":"G Kim","year":"2024","unstructured":"Kim, G., S.Y. Lee, S. Oh, et al. 2024. Anti-inflammatory effects of extracellular vesicles from Ecklonia cava on 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation in mice. International Journal of Molecular Sciences 25 (23): 12522. https:\/\/doi.org\/10.3390\/ijms252312522.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2471_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/bjd.18564","volume":"183","author":"AB Heetfeld","year":"2020","unstructured":"Heetfeld, A.B., T. Schill, S.S. Schr\u00f6der, et al. 2020. Challenging a paradigm: Skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis. British Journal of Dermatology 183 (1): 139\u2013145. https:\/\/doi.org\/10.1111\/bjd.18564.","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"2471_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00403-011-1168-2","volume":"304","author":"SC DaSilva","year":"2012","unstructured":"DaSilva, S.C., R.P. Sahu, R.L. Konger, et al. 2012. Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells. Archives of Dermatological Research 304 (1): 65\u201371. https:\/\/doi.org\/10.1007\/s00403-011-1168-2.","journal-title":"Archives of Dermatological Research"},{"issue":"5","key":"2471_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/bjd.20963","volume":"186","author":"L Puig","year":"2022","unstructured":"Puig, L., A. Costanzo, E.J. Mu\u00f1oz-El\u00edas, et al. 2022. The biological basis of disease recurrence in psoriasis: A historical perspective and current models. British Journal of Dermatology 186 (5): 773\u2013781. https:\/\/doi.org\/10.1111\/bjd.20963.","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"2471_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","volume":"28","author":"SB Larsen","year":"2021","unstructured":"Larsen, S. B., C. J. Cowley, and S. M. Sajjath et al. 2021. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28(10):1758\u20131774e8. https:\/\/doi.org\/10.1016\/j.stem.2021.07.001","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2471_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2021.07.003","volume":"103","author":"M Masalha","year":"2021","unstructured":"Masalha, M., I.Z. Ben-Dov, O. Ram, et al. 2021. H3K27Ac modification and gene expression in psoriasis. Journal of Dermatological Science 103 (2): 93\u2013100. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.07.003.","journal-title":"Journal of Dermatological Science"},{"issue":"6571","key":"2471_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh2444","volume":"374","author":"KAU Gonzales","year":"2021","unstructured":"Gonzales, K.A.U., L. Polak, I. Matos, et al. 2021. Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories. Science 374 (6571): eabh2444. https:\/\/doi.org\/10.1126\/science.abh2444.","journal-title":"Science"},{"issue":"2","key":"2471_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/exd.13850","volume":"28","author":"X Huang","year":"2019","unstructured":"Huang, X., J. Chen, W. Zeng, et al. 2019. Membrane-enriched solute carrier family 2 member 1 (SLC2A1\/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment. Experimental Dermatology 28 (2): 198\u2013201. https:\/\/doi.org\/10.1111\/exd.13850.","journal-title":"Experimental Dermatology"},{"issue":"1","key":"2471_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03704-z","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H., Q. Yao, A.G. Mariscal, et al. 2018. Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation. Nature Communications 9 (1): 1420. https:\/\/doi.org\/10.1038\/s41467-018-03704-z.","journal-title":"Nature Communications"},{"issue":"1","key":"2471_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15830-7","volume":"7","author":"JCJ Wei","year":"2017","unstructured":"Wei, J.C.J., G.A. Edwards, D.J. Martin, et al. 2017. Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micromedical device translation: From mice, rats, rabbits, pigs to humans. Scientific Reports 7 (1): 15885. https:\/\/doi.org\/10.1038\/s41598-017-15830-7.","journal-title":"Scientific Reports"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02471-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:02:48Z","timestamp":1773248568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02471-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2471"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02471-0","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Institute of Zoology, Chinese Academy of Sciences, and conducted in strict compliance with applicable guidelines and regulations. All reasonable efforts were made to minimize animal suffering and to limit the number of animals used in the experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Clinic Trial Number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}